Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PDS Biotechnology Corporation - Common Stock (NQ:PDSB)

1.045 -0.020 (-1.88%)
Delayed Quote Updated: 10:27 AM EDT, Oct 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about PDS Biotechnology Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Monday's session: top gainers and losers ↗
Via Chartmill
Keep an eye on the top gainers and losers in Monday's session. ↗
Via Chartmill
What's going on in today's session ↗
Via Chartmill
Most active stocks in Wednesday's session ↗
Via Chartmill
Keep an eye on the top gainers and losers in Wednesday's session. ↗
Via Chartmill
PDS Biotech (NASDAQ:PDSB) Posts Narrower Q1 Loss, Pre-Market Rises Over 5% ↗
Via Chartmill
News headline image
Earnings Scheduled For November 13, 2025 ↗
 
Via Benzinga
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Tuesday's session: most active stocks ↗
Via Chartmill
Unusual volume stocks are being observed in Tuesday's session. ↗
Via Chartmill
Keep an eye on the top gainers and losers in Tuesday's session. ↗
Via Chartmill
What's going on in today's after hours session ↗
Via Chartmill
What's going on in today's session ↗
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
Top movers analysis one hour before the close of the markets on 2026-09-08: top gainers and losers in today's session. ↗
Via Chartmill
Curious about the most active stocks on Tuesday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers Indaptus Therapeutics (NASDAQ:INDP) stock increased by 46.7% to $1.79 during Tuesday's regular session. The market value of their outstanding shares is at $162.5 million. PDS Biotechnology... 
Via Benzinga
Top movers analysis in the middle of the day on 2026-09-08: top gainers and losers in today's session. ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
These stocks have an unusual volume in today's session ↗
Via Chartmill
What's going on in today's session ↗
Via Chartmill
Here are the top movers in Tuesday's session. ↗
Via Chartmill
Traders are paying attention to the gapping stocks in Tuesday's session. ↗
Via Chartmill
News headline image
PDSB Q4 2025 Earnings Call Transcript ↗
PDSB Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
PDSB Q1 2026 Earnings Transcript ↗
PDSB Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Intellectual Property
News headline image
PDS Biotechnology Q1 Earnings Call Highlights ↗
PDS Biotechnology (NASDAQ:PDSB) reported a smaller first-quarter loss and highlighted changes to its late-stage head and neck cancer trial that management said could shorten development timelines and... 
Via MarketBeat
Topics Earnings
What's going on in today's after hours session ↗
Via Chartmill
News headline image
PDS BIOTECHNOLOGY CORP (NASDAQ:PDSB) Reports Q3 2025 Earnings Beat, Stock Surges 64% in Pre-Market ↗
PDS Biotech (PDSB) Q3 2025 earnings beat EPS estimates, sparking a major pre-market surge. The clinical-stage biotech also announced key progress for its lead cancer therapy. 
Via Chartmill
Topics Earnings
News headline image
A Look Ahead: PDS Biotechnology's Earnings Forecast ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.